CIK 0001739410 · <br>Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851083789
- Phone
- 203- 859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- 4 Option exercise Director acquired 33,224 shares (option exercise)
- 4 Option exercise Director acquired 14,305 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 7,124 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 21,464 shares (option exercise)
- 4 Option exercise Director acquired 14,820 shares (option exercise)
- 4 Option exercise Director acquired 3,562 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 33,244 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 599 shares at $16.04 ($9,608)
- 4 Option exercise Director acquired 2,062 shares (option exercise)
- 4 Option exercise Director acquired 3,562 shares (option exercise)
- 4 Option exercise Director acquired 2,062 shares (option exercise)
- 4 Option exercise Director acquired 14,820 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 3,910 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 22,456 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 12,044 shares (option exercise)
- 4 Option exercise Director acquired 3,562 shares (option exercise)
- 4 Option exercise Director acquired 3,562 shares (option exercise)
- 4 Open-market buy 10% owner bought 16,209 shares at an average $13.98 ($226,563)
- 4 Open-market buy 10% owner bought 79,559 shares at an average $13.99 ($1,112,977)
Page 1 of 7 · 132 filings